PharmaEngine (ROCO:4162) Short Percentage of Float


ROCO:4162 PharmaEngine Inc ROCO:4162
78 GF Score
Price NT$63.70
GF Value NT$115.11
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is PharmaEngine Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ROCO:4162 vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, PharmaEngine's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaEngine Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaEngine's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where PharmaEngine's Short Percentage of Float falls into.


ROCO:4162
78GF Score
PharmaEngine Inc ROCO:4162
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PharmaEngine (ROCO:4162) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEngine stock appears to be undervalued. The current stock price of NT$63.70 is trading 44.7% below its estimated GF Value™ of NT$115.11. GuruFocus considers PharmaEngine to be Significantly Undervalued.

Key valuation signals for ROCO:4162:

  • Short Percentage of Float:
  • GF Value™: NT$115.11 vs. price of NT$63.70 (44.7% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4162 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaEngine Business Description

Address No. 10, Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104
PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its key products and pipeline projects include ONIVYDE, a treatment for metastatic pancreatic cancer approved in multiple markets, as well as oncology candidates such as PEP07 and PEP08. It generates revenue from the sales of goods.
78GF Score

Get the complete analysis for ROCO:4162

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.70
Price
NT$115.11
GF Value